354 related articles for article (PubMed ID: 31373227)
1. Utility of Self-Destructing CRISPR/Cas Constructs for Targeted Gene Editing in the Retina.
Li F; Hung SSC; Mohd Khalid MKN; Wang JH; Chrysostomou V; Wong VHY; Singh V; Wing K; Tu L; Bender JA; Pébay A; King AE; Cook AL; Wong RCB; Bui BV; Hewitt AW; Liu GS
Hum Gene Ther; 2019 Nov; 30(11):1349-1360. PubMed ID: 31373227
[TBL] [Abstract][Full Text] [Related]
2. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
[TBL] [Abstract][Full Text] [Related]
3. Comparison of CRISPR/Cas Endonucleases for
Li F; Wing K; Wang JH; Luu CD; Bender JA; Chen J; Wang Q; Lu Q; Nguyen Tran MT; Young KM; Wong RCB; Pébay A; Cook AL; Hung SSC; Liu GS; Hewitt AW
Front Cell Neurosci; 2020; 14():570917. PubMed ID: 33132845
[TBL] [Abstract][Full Text] [Related]
4. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
5. Targeted Knockout of the Vegfa Gene in the Retina by Subretinal Injection of RNP Complexes Containing Cas9 Protein and Modified sgRNAs.
Holmgaard AB; Askou AL; Jensen EG; Alsing S; Bak RO; Mikkelsen JG; Corydon TJ
Mol Ther; 2021 Jan; 29(1):191-207. PubMed ID: 33022212
[TBL] [Abstract][Full Text] [Related]
6. Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina.
Yu W; Wu Z
Methods Mol Biol; 2019; 1950():123-139. PubMed ID: 30783971
[TBL] [Abstract][Full Text] [Related]
7. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
Haeussler M; Concordet JP
J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
[TBL] [Abstract][Full Text] [Related]
8. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
[TBL] [Abstract][Full Text] [Related]
9. Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina.
Yang TC; Chang CY; Yarmishyn AA; Mao YS; Yang YP; Wang ML; Hsu CC; Yang HY; Hwang DK; Chen SJ; Tsai ML; Lai YH; Tzeng Y; Chang CC; Chiou SH
Acta Biomater; 2020 Jan; 101():484-494. PubMed ID: 31672582
[TBL] [Abstract][Full Text] [Related]
10. Superior Fidelity and Distinct Editing Outcomes of SaCas9 Compared with SpCas9 in Genome Editing.
Yang ZX; Fu YW; Zhao JJ; Zhang F; Li SA; Zhao M; Wen W; Zhang L; Cheng T; Zhang JP; Zhang XB
Genomics Proteomics Bioinformatics; 2023 Dec; 21(6):1206-1220. PubMed ID: 36549468
[TBL] [Abstract][Full Text] [Related]
11. Identification and Analysis of Small Molecule Inhibitors of CRISPR-Cas9 in Human Cells.
Yang Y; Li D; Wan F; Chen B; Wu G; Li F; Ren Y; Liang P; Wan J; Songyang Z
Cells; 2022 Nov; 11(22):. PubMed ID: 36429003
[TBL] [Abstract][Full Text] [Related]
12. AAV5 delivery of CRISPR-Cas9 supports effective genome editing in mouse lung airway.
Liang SQ; Walkey CJ; Martinez AE; Su Q; Dickinson ME; Wang D; Lagor WR; Heaney JD; Gao G; Xue W
Mol Ther; 2022 Jan; 30(1):238-243. PubMed ID: 34695545
[TBL] [Abstract][Full Text] [Related]
13. A simple, flexible and high-throughput cloning system for plant genome editing via CRISPR-Cas system.
Kim H; Kim ST; Ryu J; Choi MK; Kweon J; Kang BC; Ahn HM; Bae S; Kim J; Kim JS; Kim SG
J Integr Plant Biol; 2016 Aug; 58(8):705-12. PubMed ID: 26946469
[TBL] [Abstract][Full Text] [Related]
14. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
Wilbie D; Walther J; Mastrobattista E
Acc Chem Res; 2019 Jun; 52(6):1555-1564. PubMed ID: 31099553
[TBL] [Abstract][Full Text] [Related]
15. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
16. Potential high-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention.
Zhang Q; Xing HL; Wang ZP; Zhang HY; Yang F; Wang XC; Chen QJ
Plant Mol Biol; 2018 Mar; 96(4-5):445-456. PubMed ID: 29476306
[TBL] [Abstract][Full Text] [Related]
17. The SpRY Cas9 variant release the PAM sequence constraint for genome editing in the model plant Physcomitrium patens.
Calbry J; Goudounet G; Charlot F; Guyon-Debast A; Perroud PF; Nogué F
Transgenic Res; 2024 Apr; 33(1-2):67-74. PubMed ID: 38573428
[TBL] [Abstract][Full Text] [Related]
18. A highly specific SpCas9 variant is identified by in vivo screening in yeast.
Casini A; Olivieri M; Petris G; Montagna C; Reginato G; Maule G; Lorenzin F; Prandi D; Romanel A; Demichelis F; Inga A; Cereseto A
Nat Biotechnol; 2018 Mar; 36(3):265-271. PubMed ID: 29431739
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.
Yin C; Zhang T; Qu X; Zhang Y; Putatunda R; Xiao X; Li F; Xiao W; Zhao H; Dai S; Qin X; Mo X; Young WB; Khalili K; Hu W
Mol Ther; 2017 May; 25(5):1168-1186. PubMed ID: 28366764
[TBL] [Abstract][Full Text] [Related]
20. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.
Ideno N; Yamaguchi H; Okumura T; Huang J; Brun MJ; Ho ML; Suh J; Gupta S; Maitra A; Ghosh B
Lab Invest; 2019 Jul; 99(8):1233-1244. PubMed ID: 30728464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]